Scott Sharetts, MD
Neurology · Westampton, NJNPI 1437202116
Payments from drug & device makers
Across 260 payments — averaging $14.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$899
- Biogen$316
- Novartis$248
- Eisai Inc.$232
- UCB, Inc.$226
- Bristol Myers Squibb$216
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,84899%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 71 | $899 |
| Biogen | 17 | $316 |
| Novartis | 18 | $248 |
| Eisai Inc. | 15 | $232 |
| UCB, Inc. | 13 | $226 |
| Bristol Myers Squibb | 9 | $216 |
| Pfizer | 12 | $214 |
| Teva Pharmaceuticals USA, Inc. | 15 | $187 |
| EMD Serono, Inc. | 18 | $169 |
| E.r. Squibb & Sons, L.L.C. | 10 | $158 |
| Scilex Pharmaceuticals Inc. | 9 | $135 |
| Sunovion Pharmaceuticals Inc. | 8 | $127 |
| Amgen | 6 | $108 |
| Lundbeck LLC | 4 | $67 |
| Sanofi | 4 | $58 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Upsher-smith Laboratories LLC | 2 | $34 |
| AstraZeneca | 2 | $31 |
| Adamas Pharmaceuticals, Inc. | 2 | $28 |
| Ceribell, Inc. | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Argenx US, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Aucta Pharmaceuticals, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Banner Life Sciences, LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $12 |
| Assertio Therapeutics, Inc. | 1 | $12 |
How this compares
$3,877 in reported general payments places this provider in the 55th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dimethyl Fumarate | 24 | $12,633 |
| Memantine Hcl | 174 | $3,564 |
| Carbamazepine | 31 | $2,799 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $2,681 |
| Lacosamide | 37 | $2,082 |
| Levetiracetam | 92 | $1,880 |
| Pregabalin | 31 | $1,740 |
| Propranolol Hcl | 13 | $958 |
| Gabapentin | 86 | $893 |
| Primidone | 37 | $870 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 43 | $869 |
| Memantine Hcl ErMemantine Hcl | 13 | $511 |
| Sumatriptan Succinate | 20 | $457 |
| Donepezil Hcl | 17 | $222 |
| Baclofen | 13 | $177 |
Paid to pharmacies, not to this prescriber.
Other neurology in Westampton
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.